Koichi Toda
Prof Koichi Toda, MD., PhD joined research program regarding artificial heart in National Cardiovascular Center (NCVC) in 1993 and received Ph.D. Degree certified by OUGM in 1996. He then worked as a post-doctoral fellow in the Department of Cardiovascular Surgery, Columbia University and passed USMLE (1996-1998). Upon completion, he completed Thoracic Cardiovascular residency in Ochsner Clinic, New Orleans (1998-2000) and clinical fellowship in Cardiovascular Surgery in Brown University, Rhode Island (2000-2001). After returning to Japan, he worked as an attending cardiovascular surgeon in OUGM affiliated hospitals and NCVC (2001-2012) and promoted to Associate Professor and Clinical Professor of Cardiovascular Surgery at OUGM (2012 - Present). His surgical specialty includes mechanical circulatory support, heart transplant, heart and lung transplant, minimally invasive surgery, and regenerative therapy and he has more than 250 publications related to cardiovascular surgery. He also works as Board member of International Federation for Artificial Organs (IFAO) (2016-2021), ISMCS (International Society for Mechanical Circulatory Support) (2019-Present), Japanese Society of Artificial Organs (JSAO) (2013 - 2019), and Editorial Board member of Surgery Today and Artificial Organs. He has also hosted the 57th Annual Meeting of the JSAO in 2019.
|
|
|
Toru MasuzawaProf Toru Masuzawa received the B.S., M.S., and Ph.D. degrees from Tokyo Denki University, in 1982, 1984 and 1991, respectively. In 1987, he was a Research Assistant with the Department of Precision Mechanical Engineering, University of Tokyo. From 1990 to 1997, he was a Research Associate with the Department of Artificial Organs, National Cardiovascular Center Research Institute, Osaka, Japan. He is currently a Professor of the domain of mechanical systems engineering. He is also the Dean of the College of Engineering and Graduate School of Science and Engineering, Ibaraki University, Hitachi, Japan. His current research focuses on medical mechatronics such as magnetically suspended blood pumps and artificial hearts. Prof Masuzawa is the President of the International Federation for Artificial Organs and the board member of the International Society for Mechanical Circulatory Support, and the Japanese Society for Artificial Organs.
|
|
|
Xiaocheng LiuProf Xiaocheng Liu is currently the President of TEDA International Cardiovascular Hospital, China, and a visiting professor of Tokyo Medical and Dental University. He took his cardiovascular surgery fellowship in Prince Charles Hospital, Brisbane, Australia. Thereafter, Prof Liu founded Mudanjiang Cardiovascular Hospital in Heilongjiang Province, China, where he performed the first heart-lung transplant in China. Since 2009, he has led the TICH team to work with the engineers of China Academy of Launch Vehicle Technology to develop the implantable left ventricular assist device (HeartCon also known as ¡°Rocket Heart¡±), China's first model based on third-generation LVAD technology. He was the principal investigator who led more than 10 hospitals in China to successfully complete a clinical trial of 50 cases of Rocket Heart. The device was approved by the National Medical Products Administration (Chinese FDA) for marketing in July 2022. As a cardiovascular surgeon, Prof Liu has performed more than 10,000 heart surgeries and still does more than 300 emergency and critical surgeries every year.
|
|
|
Tomohiro NishinakaProf Tomohiro Nishinaka is the Director of the Department of Artificial Organs, National Cerebral and Cardiovascular Center Research Institute, which focuses on the practical application of medical devices such as ECMO systems and ventricular assist devices for the treatment of severe heart failure and respiratory failure. He is also the current Secretary-General of APSAO.
|
|